Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.010.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 9.96% | 21.22% | |||
| Gross Profit | -9.96% | -21.22% | |||
| SG&A Expenses | 7.21% | 25.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.49% | 23.34% | |||
| Operating Income | -8.49% | -23.34% | |||
| Income Before Tax | -10.43% | -22.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.43% | -22.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.43% | -22.44% | |||
| EBIT | -8.49% | -23.34% | |||
| EBITDA | -8.48% | -23.35% | |||
| EPS Basic | 3.17% | -9.98% | |||
| Normalized Basic EPS | 3.15% | -9.97% | |||
| EPS Diluted | 3.17% | -9.98% | |||
| Normalized Diluted EPS | 3.15% | -9.97% | |||
| Average Basic Shares Outstanding | 14.05% | 11.32% | |||
| Average Diluted Shares Outstanding | 14.05% | 11.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||